Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
Headache. 2023 Jan;63(1):40-50. doi: 10.1111/head.14448. Epub 2023 Jan 12.
This systematic review provides a summary and evaluation of cases of migraine aura-like episodes elicited by sclerotherapy of veins of the lower extremities and discusses possible underlying mechanisms.
Sclerotherapy is a commonly used treatment for varicose veins. Symptoms resembling migraine aura have been reported during and following sclerotherapy of the lower extremities, suggesting that sclerotherapy may elicit migraine aura.
We searched PubMed for articles reporting neurological complications that were transient and fully reversible following sclerotherapy treatment for varicose veins in the lower limbs. There were no restrictions regarding article language or publication date. Only original studies and case reports were included. Two authors independently reviewed included articles in detail. Data were extracted from each article, including details on symptoms, previous migraine history, sclerotherapy method, and the presence of a right-to-left cardiac shunt in patients. We evaluated whether episodes fulfilled modified International Classification of Headache Disorders, 3rd edition, criteria for 1.2 Migraine with aura or 1.5.2 Probable migraine with aura.
The search yielded 777 articles, 28 of which were included. Twenty-six articles reported 119 episodes of transient neurological symptoms in 34,500 sclerotherapy sessions. Two additional articles reported six episodes of transient neurological symptoms with no specification of the number of sessions. Of the 125 episodes, 119 involved transient visual disturbances, and eight met the modified criteria for Probable migraine with aura. In most episodes (98%), clinical information was insufficient to determine if the criteria were fulfilled.
Symptoms that are clinically indistinguishable from migraine with aura attacks may occur following sclerotherapy, although this likely is rare. Microembolization through a right-to-left shunt triggering cortical spreading depolarization is a possible mechanism. Our findings are limited by infrequent specific assessments for neurological complications and a low level of detail in the description of symptoms in the available literature. Future prospective studies are needed to determine this phenomenon's incidence and underlying mechanisms.
本系统评价总结和评估了下肢静脉硬化疗法诱发偏头痛样发作的病例,并讨论了可能的潜在机制。
硬化疗法是一种常用于治疗静脉曲张的方法。下肢硬化疗法期间和之后出现类似于偏头痛先兆的症状表明,硬化疗法可能会诱发偏头痛先兆。
我们在 PubMed 上搜索了报告下肢静脉曲张硬化治疗后出现短暂且完全可逆的神经系统并发症的文章。对文章语言和发表日期没有限制。仅纳入原始研究和病例报告。两位作者独立详细审查了纳入的文章。从每篇文章中提取数据,包括症状、既往偏头痛史、硬化疗法方法以及患者是否存在右向左心内分流的详细信息。我们评估了这些发作是否符合偏头痛国际分类第 3 版的修改标准,即 1.2 偏头痛伴先兆或 1.5.2 可能的偏头痛伴先兆。
搜索结果共 777 篇文章,其中 28 篇被纳入。26 篇文章报道了 34500 次硬化治疗中 119 次短暂性神经症状发作。另外两篇文章报道了 6 次短暂性神经症状发作,但未具体说明治疗次数。在 125 次发作中,119 次涉及短暂性视觉障碍,8 次符合可能的偏头痛伴先兆的修改标准。在大多数发作中(98%),临床信息不足以确定是否符合标准。
硬化疗法后可能会出现与偏头痛先兆发作难以区分的症状,尽管这种情况可能很少见。通过右向左分流触发皮质扩散性去极化的微栓塞是一种可能的机制。我们的研究结果受到可用文献中对神经系统并发症的评估频率低且症状描述详细程度低的限制。需要进一步进行前瞻性研究以确定这种现象的发生率和潜在机制。